HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum

HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases ...

HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors

Its lead T-Cell Engager HCW11-018b is shown to penetrate into the tumor microenvironment with potent and antigen-specific anti-pancreatic cancer ...
AOL

Why Is Penny Stock HCW Biologics Surging On Monday?

HCW Biologics Inc (NASDAQ:HCWB) stock is trading higher during Monday premarket with a strong session volume of 10.03 million versus an average volume of 48.02K, as per data from Benzinga Pro. HCW ...
Yahoo Finance

HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan

MIRAMAR, Fla., April 27, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...
Benzinga.com

1HCWB : What's Going On With HCW Biologics Stock Monday?

HCW Biologics, Inc. (NASDAQ:HCWB) shares are trading higher on Monday after the company announced clearance from the Food and Drug Administration (FDA) for its Phase 1 trial of HCW9302. The Details: ...
Benzinga.com

HCW Biologics Shares Soar On Breakthrough Second-Generation Cancer Immunotherapy

HCW Biologics Inc. (NASDAQ:HCWB) shares were up Monday after the company announced a breakthrough in developing second-generation pembrolizumab-based immunotherapies for solid tumors. What to Know: ...
Nasdaq

HCW Biologics Reports Positive Results For HCW9206 And Opens Commercial Partnership Talks

(RTTNews) - HCW Biologics Inc. (HCWB), a clinical-stage biopharmaceutical company developing immunotherapies targeting chronic inflammation, announced the presentation of promising study results for ...
BioWorld

Items Tagged with 'HCW Biologics Inc.'

Optimism for the potential of a bifunctional fusion protein complex in development at HCW Biologics Inc. for the potential treatment of pancreatic cancer jolted company shares (NASDAQ:HCWB) skyward to ...
Nasdaq

Investors in HCW Biologics (NASDAQ:HCWB) have unfortunately lost 15% over the last year

It's easy to feel disappointed if you buy a stock that goes down. But often it is not a reflection of the fundamental business performance. The HCW Biologics Inc. (NASDAQ:HCWB) share price is down 15% ...
manilatimes

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results

MIRAMAR, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the "Company” or "HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...
Taiwan News

HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune

HCW Biologics retains royalty-free option to reclaim the rights to the Americas territory MIRAMAR, Fla., Feb. 13, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCW Biologics”) (NASDAQ: HCWB), a ...